Synthesis and Antibacterial Activity of 1-Substituted-methyl Carbapenems

Chemical and Pharmaceutical Bulletin

Volumn 40, Issue 9, 1992, Pages 2410-2418

  Sendo, Yuji ^a   Kii, Makoto ^a   Sakanoue, Miki ^a   Motokawa, Kiyoshi ^a   Kimura, Yasuo ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

1 substituted methyl carbapenem; 1 substituted methyl carbapenem; 1 acetoxymethyl carbapenem; 1 cyanomethyl carbapenem; 1 fluoromethylcarbapenem; 1 hydroxymethyl carbapenem; antibacterial activity; carbapenem antibiotic; methicillin resistant S. aureus (MRSA); lactam antibiotic

Indexed keywords

1BETA FLUOROMETHYL 6 (1 HYDROXYETHYL) 2 [(1,3,4 THIADIAZOL 2 YL)THIOMETHYL]CARBAPEN 2 EM 3 CARBOXYLIC ACID; CARBAPENEM DERIVATIVE; IMIPENEM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; STRUCTURE ACTIVITY RELATION;

ANTIBIOTICS, LACTAM; BACTERIA; CARBAPENEMS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS;

EID: 0026761869     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.40.2410     Document Type: Article

References (13)

1. D. H. Shih, F. Baker, L. Cama and B. G. Christensen, Heterocycles, 21, 29 (1984); b) A. Andrus, F. Baker, F. A. Bouffard, L. D. Cama, B. G. Christensen, R. N. Guthikonda, J. V. Heck, D. B. R. Johnston, W. J. Leanza, R. W. Ratcliffe, T. N. Salzmann, S. M. Schmitt, D. H. Shih, N. V. Shah, K. J. Wildonger and R. R. Wilkening, “Recent Advances in the Chemistry of LLactam Antibiotics,” ed. by A. G. Brown and S. M. Roberts, The Royal Society of Chemistry, London, 1984, p. 86.
2. M. Sunagawa, H. Matsumura, T. Inoue, M. Fukasawa and M. Kato, J. Antibiot., 43, 519 (1990).
3. J. Banville, C. Bachand, J. Corbeil, J. Desiderio, J. Fung-Tomc, P. Lapointe, A. Martel, V. S. Rao, R. Remillard, M. Menard, R. E. Kessler and R. A. Partyka, Abstracts of Papers, 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September—October 1991, p. 237; b) Y. Nagao, T. Abe, H. Shimizu, T. Kumagai and Y. Inoue, J. Chem. Soc., Chem. Commun., 1989, 821; c) R. L. Rosati, L. V. Kapili, P. Morrissey and J. A. Retsema, J. Med. Chem., 33, 291 (1990); d) N. V. Shah and L. D. Cama, Heterocycles, 25, 221 (1987).
4. R. Filler and Y. Kobayashi, “Biomedical Aspects of Fluorine Chemistry,” Kodansha Ltd., Tokyo, 1982; b) J. Mann, Chem. Soc. Rev., 16. 381 (1987); c) J. T. Welch. Tetrahedron. 43. 3123 (1987).
5. M. Imuta, S. Uyeo and T. Yoshida, Chem. Pharm. Bull., 39, 658 (1991); b) M. Imuta, H. Itani, H. Ona, Y. Hamada, S. Uyeo and T. Yoshida, Kodansha Ltd., Tokyo, 39, 663 (1991); c) M. Imuta, H. Itani, H. Ona, T. Konoike, S. Uyeo, Y. Kimura, H. Miwa, S. Matsuura and T. Yoshida. Kodansha Ltd., Tokyo, 39. 672 (1991).
6. R. N. Guthikonda, L. D. Cama, M. Quesada, M. F. Woods, T. N. Salzmann and B. G. Christensen. J. Med. Chem., 30. 871 (1987).
7. M. Imuta, S. Uyeo and T. Yoshida, Chem. Pharm. Bull., 39, 658 (1991); b) M. Imuta, H. Itani, H. Ona, Y. Hamada, S. Uyeo and T. Yoshida, Kodansha Ltd., Tokyo, 39, 663 (1991); c) M. Imuta, H. Itani, H. Ona, T. Konoike, S. Uyeo, Y. Kimura, H. Miwa, S. Matsuura and T. Yoshida. Kodansha Ltd., Tokyo, 39. 672 (1991).
8. M. Imuta, S. Uyeo and T. Yoshida, Chem. Pharm. Bull., 39, 658 (1991); b) M. Imuta, H. Itani, H. Ona, Y. Hamada, S. Uyeo and T. Yoshida, Kodansha Ltd., Tokyo, 39, 663 (1991); c) M. Imuta, H. Itani, H. Ona, T. Konoike, S. Uyeo, Y. Kimura, H. Miwa, S. Matsuura and T. Yoshida. Kodansha Ltd., Tokyo, 39. 672 (1991).
9. R. O. Hutchins and D. Kandasamy, J. Am. Chem. Soc., 95, 6131 (1973).
10. W. J. Middleton. J. Ore. Chem., 40. 574 (1975).
11. H. R. Pfaendler, J. Gosteli and R. B. Woodward, J. Am. Chem. Soc., 101. 6306 (1979).
12. M. Ohtani, F. Watanabe and M. Narisada, J. Org. Chem., 49, 5271 (1984).
13. For classification of H-MRSA and L-MRSA, see K. Murakami, K. Nomura, M. Doi and T. Yoshida, Antimicrob. Agents Chemother., 31, 1307 (1987).